Dapagliflozin reduced the combined risk of worsening heart failure

Dapagliflozin reduced the combined risk of worsening heart failure or cardiovascular death among patients with heart failure and a mildly reduced or preserved ejection fraction.

Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction | NEJM

Original Article from The New England Journal of Medicine — Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction